| 2024-04-24 | -1.15 % |
|
| 2024-04-23 | +3.96 % |
|
| 2024-04-22 | +0.89 % |
|
| 2024-04-19 | -1.4 % |
|
| 2024-04-17 | -0.56 % |
|
| 2024-04-11 | -0.56 % |
|
| 2024-03-21 | +0.45 % |
|
| 2024-03-14 | +3.54 % |
|
| 2024-03-12 | +5.73 % |
- Summary: Creative Planning significantly increased its position in West Pharmaceutical Services, Inc. (WST) by 1,287.0% during the 3rd quarter, acquiring additional shares, along with other hedge funds and institutional investors making changes to their positions, leading to a 5.73% increase in WST stock last night.
Reason for WST Stock Increase: The increase in WST stock price can be attributed to significant institutional investment and interest from various hedge funds, including Creative Planning, acquiring additional shares and raising their positions in the company, contributing to a positive market outlook for West Pharmaceutical Services.
- The article discusses how Creative Planning significantly increased its position in West Pharmaceutical Services, Inc. with other hedge funds and institutional investors also making changes to their positions in the company, causing the stock to go up by 5.73% last night. The increase in stock price is attributed to the growing interest from investors like Creative Planning and other firms making significant stakes in West Pharmaceutical Services, Inc.
- West Pharmaceutical Services Inc (WST) stock went up by 5.73% due to gains in the Technology, Consumer Services and Industrials sectors, with the overall U.S. stock market experiencing positive movements as well.
|
| 2024-02-28 | -0.27 % |
|
| 2024-02-27 | -1.38 % |
- Summary: Natixis Advisors L.P. increased its position in West Pharmaceutical Services, Inc. (WST) by 13.5% in the 3rd quarter, while other institutional investors also made changes to their positions in the company. Despite positive financial results with a higher-than-expected quarterly EPS, West Pharmaceutical Services stock went down by -1.38% last night, possibly due to market sentiment or other industry factors.
Reason for Stock Decline: Various factors could have contributed to the decline in West Pharmaceutical Services stock, including general market conditions, changes in investor sentiment, analyst ratings, and potential profit-taking by investors given the stock's recent performance.
- The article discusses the recent decrease in West Pharmaceutical Services (WST) stock by -1.38%, citing that Connor Clark & Lunn Investment Management Ltd. lowered its holdings, leading to a 73.8% decrease in ownership during the 3rd quarter, along with other institutional investors making changes to their positions, ultimately resulting in a downturn in the stock price.
- The article discusses Stifel Financial Corp boosting its stake in West Pharmaceutical Services, Inc. and various other institutional investors increasing their positions, leading to a consensus "Moderate Buy" rating, but due to cautious ratings and analyst expectations, the stock of West Pharmaceutical Services (WST) went down by -1.38%.
|
| 2024-02-23 | +2.1 % |
|
| 2024-02-20 | -3.28 % |
|
| 2024-02-16 | +3.24 % |
|
| 2024-02-15 | -14.08 % |
|
| 2024-02-07 | +3.7 % |
|
| 2024-02-06 | +0.16 % |
|
| 2024-02-05 | +4.36 % |
|
| 2024-02-02 | -0.13 % |
|
| 2024-02-01 | +2.27 % |
|
| 2024-01-31 | -0.81 % |
|
| 2024-01-30 | +1.51 % |
|
| 2024-01-29 | +2.53 % |
|
| 2024-01-25 | +1.58 % |
|
| 2024-01-22 | +1.28 % |
|
| 2023-12-06 | -0.16 % |
|
| 2023-12-04 | -0.26 % |
|
| 2023-11-13 | -1.03 % |
|
| 2023-11-01 | +1.07 % |
|
| 2023-10-27 | -1.96 % |
|
| 2023-10-26 | -8.57 % |
|
